Manufacturers Life Insurance Company, The Vaxcyte, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 153,152 shares of PCVX stock, worth $4.99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
153,152
Previous 158,528
3.39%
Holding current value
$4.99 Million
Previous $13 Million
55.44%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding PCVX
# of Institutions
345Shares Held
136MCall Options Held
348KPut Options Held
250K-
Ra Capital Management, L.P. Boston, MA12.2MShares$397 Million9.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$392 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.8MShares$383 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$324 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA6.42MShares$209 Million0.05% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $1.93B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...